Influence of low molecular weight heparin on the lipometabolism in hemodialysis patients
尹良红,郑绮宜,蔡启德,陈湛华,朱宁,M.Molzahn,W.Fassbinder
DOI: https://doi.org/10.3321/j.issn:1000-4718.2001.07.015
2001-01-01
Abstract:AIM: To compare the influence of low molecular weight heparin(LMWH) (Fragmin, Kabi Chemie Corp., Mnchen) and conventional heparin (CH) on anticoagulation and lipometabolism in patients on chronic hemodialysis (CHD).METHODS: 27 patients on CHD underwent 6 months LMWH-treatment, then switched to 6 months CH-treatment for anticoagulation during dialysis. Total plasma cholesterol (TCh), triglyceride (TG), high-density lipoprotein cholesterol(HDL-Ch), HDL 2-Ch, HDL 3-Ch, low density lipoprotein, LDL (LDL), apolipoprotein A 1 (Apo-L A 1), Apo-L B, hemoglobin(Hb), platelet(Plt), kaolin partial thromboplastin time(KPTT), bleed time (BT), coagulation time(CT), alanine transaminase(ALT), aspartate aminotransferase(AST) were measured every two months.RESULTS: During LMWH-treatment, whole KPTT, BT, CT, TCh, TG, LDL, Apo-L A 1 and Apo-L B decreased significantly.Symptoms such as haemorrhage and itching were alleviated. However, after switching back to CH, the parameters reversed, HDL-Ch and the subfractions of HDL-Ch remained nearly unchanged.CONCLUSION: LMWH could improve the anticoagulative effect and lipometabolism in CHD patients. and alleviated the symptoms such as haemorrhage and itching. More importantly, the Lifequality of CHD patients could be improved. [